FDA Clears First Ever Bi-directionally Retrievable Vena Cava Filter from Crux Biomedical
09:00 EDT 18 Jul 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Crux Biomedical announced it has received U.S. Food and Drug
Administration (FDA) clearance for its novel inferior vena cava filter
(VCF) with bi-directional retrieval. VCF are designed to trap blood
clots that can lead to poten...
Other Sources for this Article
For Crux Biomedical
Ed Stevens, 727-412-1541
estevens@chasepr.com
More From BioPortfolio on "FDA Clears First Ever Bi-directionally Retrievable Vena Cava Filter from Crux Biomedical"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
